Skip to search formSkip to main contentSkip to account menu

Recombinant Adenovirus-p53

Known as: Recombinant Adenovirus Encoding p53, rAd-p53, rAd/p53 
A replication-defective, recombinant adenoviral vector encoding the wild-type human tumor-suppressor protein p53 gene with potential antineoplastic… 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2016
2016
Objective This paper aimed to assess the physiological effects of p53 on glucose homeostasis in vivo. Methods A recombinant… 
2016
2016
e17561Background: to evaluate the activity and mechanism of rAd-p53 combined with chemotherapeutics in treatment of ATC in vitro… 
2016
2016
The present study was conducted to identify the anti-tumor effects of rAd/p53, which is a recombinant human serotype 5 adenovirus… 
Review
2015
Review
2015
Cancer of the pancreas is one of the tumors with the worst prognosis. Radiation therapy has been proposed as an exclusive or… 
2010
2010
OBJECTIVE To explore the effect of recombinant human adenovirus p53 (rAd-p53) combined with cisplatin on the expression of human… 
2010
2010
Objective To investigate the effects of the recombinant adenoviral vector rAd-p53 on hepatic cell carcinoma.Methods 20 rabbits… 
2009
2009
Purpose: Oral leukoplakia is a well-recognized precancerous lesion of squamous cell carcinoma. When accompanied with abnormal p53… 
2008
2008
ObjectiveTo evaluate transduction efficiency with recombinant adenovirus-mediated p53 (rAd/p53) therapy in a human colon cancer… 
2008
2008
Objective:To investigate the inhibitory effect of recombinant human endostatin(ES)combined with rAd/P53 on transplanted human… 
2007
2007
Background and purpose:There is a tendency to treat tumors through multiple genes and multiple targeting but there has been no…